SCHEMBL14873170

SCHEMBL14873170

CC(C)(C)OC(=O)N1[C@@H]2CC[C@H]1C[C@H](O[C@H]1CC[C@H](Oc3ccc(-n4cnnn4)cc3)CC1)C2

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 8/20 0.53
MAPT P10636 5/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
POLB P06746 1/20 0.45
ADRB2 P07550 1/20 0.45
TP53 P04637 2/20 0.42
ALDH1A1 P00352 1/20 0.41
ALOX15 P16050 1/20 0.41
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14860959 0.86 MAPT (0.52) MAPTMEN1KMT2ASMN1; SMN2POLB
SCHEMBL14860961 0.86 MAPT (0.52) MAPTMEN1KMT2ASMN1; SMN2POLB
SCHEMBL14873081 0.81 GPR119 (0.49) GPR119CHRM2CHRM1CHRM3
SCHEMBL3372121 0.79 GPR119 (0.58) GPR119MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL14873161 0.78 GPR119 (0.72) GPR119CHRM2CHRM1CHRM3
SCHEMBL14873089 0.77 GPR119 (0.48) GPR119CHRM2CHRM1CHRM3
SCHEMBL14873077 0.76 GPR119 (0.47) GPR119CHRM2CHRM1CHRM3
SCHEMBL14873092 0.75 GPR119 (0.48) GPR119CHRM2CHRM1CHRM3
SCHEMBL14873175 0.75 GPR119 (0.48) GPR119CHRM2CHRM1CHRM3
SCHEMBL14873080 0.74 GPR119 (0.52) GPR119CHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013055910-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2013-04-18 WO disclosed